Stanford Graduate School of Business (USA)
-
Axel Springer in 2016: From Transformation to Acceleration
Burgelman, R; Siegel, R; Kissick, RCase SGSB-E610-EEntrepreneurshipAs of 2016, Mathias Döpfner, chief executive officer (CEO) of Axel Springer SE, had successfully transitioned the German publishing house through a major digital transformation in the world of journalism. Given the massive disruption that had occurred over the previous two decades with how people consumed news, this was no small feat. During this time, many newspapers, magazines, and journals failed to keep up with the rapidly changing industry...Starting at €8.20
-
Axel Springer in 2014: Strategic Leadership of the Digital Media Transformation - Teaching Note
Burgelman, R; Siegel, R; Luther, JTeaching Note SGSB-E522TN-EEntrepreneurshipIn 2013, Mathias Döpfner, CEO of the publishing house Axel Springer SE, a premier source of content in Germany, with its popular newspapers and magazines such as Bild and Die Welt, was evaluating the progress of his company’s digital transformation. The advent of the digital revolution at the end of the twentieth century had caused an appreciable shift in the publishing industry. Traditional print media players were confronted with major techno...Starting at €0.00
-
Managing Local Political Risk: Parking the Tata Nano (A) - (C) - Teaching note
Jha, S, Schifrin, DTeaching Note SGSB-P78TN-EEconomicsManaging Local Political Risk: Parking the Tata Nano highlights the role of political geography in shaping risks to businesses. The case has three parts: an (A) case, (B) case, and (C) case. The (A) case is set in 2006 and discusses the decision Tata Motors must make about where in India to locate a manufacturing plant to build the Nano – the world’s cheapest car. The (A) case presents four possible locations, and the students must evaluate which...Starting at €0.00
-
Invitrogen (A)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209A-EStrategyFounded in 1987, Invitrogen was one of the largest catalog life science companies in the industry. Its customers came from academic research, biotechnology and pharmaceutical companies and government laboratories. Scientists viewed Invitrogen as a one-stop shop for all major molecular biology, biochemistry and cell culture reagent products, with prices ranging from a hundred dollars to a few thousand dollars.Starting at €8.20
-
Invitrogen/Life Technologies (B)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209B-EStrategyOn June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.Starting at €5.74
-
Waste Management's Organic Growth Group
Burgelman, R; Siegel, R; Uribe, TCase SGSB-SM210-EStrategyIt was 2005 and David Steiner, CEO of Waste Management (WM), had just received a report from an internal advisory panel created some months before to assess the future of the waste management industry and propose how the company’s strategy should be adapted. The core of this report was the recommendation to create a special unit within the company, chartered with the central purpose of identifying ways to extract value from waste through new and ...Starting at €8.20
-
The Chinese Wireless Communications Industry in 2012 and Beyond: An Industry Note - Teaching Note
Burgelman, R; Gang, Zheng,, Yajuan, WangTeaching Note SGSB-SM227TN-EStrategyThis industry note provides an extensive overview of the wireless communications industry in China at the end of 2012. At the time China had over 1.1 billion mobile subscribers, and the country was predicted to have 500 million smartphones in use by the end of 2013. The note discusses the industry’s value chain (carriers, device manufactures, component providers, content and applications providers, and telecom equipment providers), and the role o...Starting at €0.00
-
Sirum: Scaling a “Tech-for-Good” Medication Donation Platform
Siegelman, Russell; Montgomery, LucyCase SGSB-E815-EEntrepreneurshipKiah Williams started SIRUM as a Stanford undergraduate alongside her classmates Adam Kircher and George Wang. Nearly two decades later, the medication donation nonprofit was now operating in five states across the country and had helped facilitate medication donations to reach 150,000 uninsured and underinsured patients. SIRUM’s technology enabled donors with excess medication supply to donate unexpired, sealed, non-opioid medications to those...Starting at €8.20
-
Atticus Law
Siegelman, Russell; Freiman, AandrewCase SGSB-E818-EEntrepreneurshipThis case follows Sam Byker, the Founder and CEO of Atticus, as he creates, scales, and fundraises for the company. Atticus is a platform that serves individuals in need by connecting them with law firms that can help. The case covers the company’s history from its inception through to its Series A financing. The case explores the tension Byker faces between Atticus’ opportunities for growth and maintaining focus on the company’s mission when se...Starting at €8.20
-
Byteboard: Reinventing the Technical Interview (A)
Siegelman, Russell; Mirabile, DominicCase SGSB-E768A-EEntrepreneurshipByteboard aims to replace the pre-on-site technical interview for software engineers with a more effective, efficient, and equitable web-based assessment. The case follows the founding team’s journey from problem definition and customer development through the testing of their minimum viable product and validation of their core value hypothesis. By recounting Byteboard’s early quest towards product-market fit, the case poses several key questio...Starting at €8.20